Landfar Bio-medicine Co., Ltd. Class A (000504.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.87B
Enterprise Value2.85B
P/E Ratio125.91
PEG Ratio0.31
Price/Sales Ratio3.64
Price/Book Ratio10.35
Enterprise/Revenue3.48
Enterprise/EBITDA166.47

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.03
Operating Margin0
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.08

Income Statement

Revenue415.94M
Revenue/Share2.27
Gross Profit91.8M
EBITDA29.14M
Net Income28.83M
Diluted EPS0.09

Balance Sheet

Total Cash309.9M
Total Cash/Share0.94
Total Debt190.34M
Total Debt/Equity0.72
Current Ratio1.51
Book Value Per Share1.04

Price History

52-Week Change-18.06
52-Week High14.04
52-Week Low7.02
Moving Average 50 Days9.86
Moving Average 200 Days9.13

Statistics

Average Volume22.24M
Shares Outstanding330.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.06
Last Split Factor13:10
Last Split DateJanuary 15, 2007
AD